AU2001239000A1 - Agent for treating hepatitis C containing Ukrain - Google Patents

Agent for treating hepatitis C containing Ukrain

Info

Publication number
AU2001239000A1
AU2001239000A1 AU2001239000A AU3900001A AU2001239000A1 AU 2001239000 A1 AU2001239000 A1 AU 2001239000A1 AU 2001239000 A AU2001239000 A AU 2001239000A AU 3900001 A AU3900001 A AU 3900001A AU 2001239000 A1 AU2001239000 A1 AU 2001239000A1
Authority
AU
Australia
Prior art keywords
ukrain
agent
treating hepatitis
hepatitis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239000A
Inventor
Wassyl Nowicky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASSYLI NOWICKY
Original Assignee
WASSYLI NOWICKY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASSYLI NOWICKY filed Critical WASSYLI NOWICKY
Publication of AU2001239000A1 publication Critical patent/AU2001239000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001239000A 2000-03-22 2001-03-20 Agent for treating hepatitis C containing Ukrain Abandoned AU2001239000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT481/2000 2000-03-22
AT0048100A AT408719B (en) 2000-03-22 2000-03-22 AGENT FOR TREATING HEPATITIS C
PCT/AT2001/000076 WO2001070203A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Publications (1)

Publication Number Publication Date
AU2001239000A1 true AU2001239000A1 (en) 2001-10-03

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239000A Abandoned AU2001239000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis C containing Ukrain

Country Status (17)

Country Link
JP (1) JP2003527414A (en)
KR (1) KR20020087045A (en)
CN (1) CN1416347A (en)
AT (1) AT408719B (en)
AU (1) AU2001239000A1 (en)
BG (1) BG107088A (en)
BR (1) BR0107211A (en)
CA (1) CA2389173A1 (en)
EA (1) EA200200584A1 (en)
HR (1) HRP20020367A2 (en)
IL (1) IL149314A0 (en)
IS (1) IS6360A (en)
MA (1) MA25509A1 (en)
MX (1) MXPA02004993A (en)
NO (1) NO20022253L (en)
PL (1) PL365000A1 (en)
WO (1) WO2001070203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (en) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Process for reacting alkaloids.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
EP2083825A4 (en) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (en) * 2015-07-13 2017-01-25 张如安 Beverage for killing hepatitis B virus
CN106109538A (en) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 The pharmaceutical composition for the treatment of hepatitis C

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (en) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "METHOD FOR DIAGNOSTICING AND FOR THE THERAPEUTIC TREATMENT OF TUMORS AND / OR INFECTIOUS DISEASES OF DIFFERENT TYPES WITH PREPARATIVE USE OF ALKALOID COMPOUNDS OR THEIR SALTS"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (en) * 1989-04-17 1991-01-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

Also Published As

Publication number Publication date
IL149314A0 (en) 2002-11-10
EA200200584A1 (en) 2003-06-26
IS6360A (en) 2002-04-24
MXPA02004993A (en) 2003-10-14
BG107088A (en) 2003-05-30
BR0107211A (en) 2004-01-06
KR20020087045A (en) 2002-11-21
CA2389173A1 (en) 2001-09-27
AT408719B (en) 2002-02-25
MA25509A1 (en) 2002-07-01
ATA4812000A (en) 2001-07-15
NO20022253D0 (en) 2002-05-10
HRP20020367A2 (en) 2004-02-29
WO2001070203A2 (en) 2001-09-27
PL365000A1 (en) 2004-12-27
WO2001070203A3 (en) 2002-09-06
JP2003527414A (en) 2003-09-16
NO20022253L (en) 2002-05-10
CN1416347A (en) 2003-05-07

Similar Documents

Publication Publication Date Title
AU2001231104A1 (en) Methods for treating diabetes
AU2002337765A1 (en) Compounds useful for treating hepatitus c virus
EP1346724A4 (en) Remedies for hepatitis c
AU2001284584A1 (en) Chemical compounds
AU1099000A (en) Novel compounds and compositions for treating hepatitis c infections
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
AU2002225730A1 (en) Compounds
AU2001262886A1 (en) Chemical compounds
AU6200999A (en) Treatment for fabrics
AU2001228638A1 (en) Chemical compounds
SI0970917T1 (en) Method for coating peroxide compounds
AUPQ661800A0 (en) Insulin-potentiating compounds
ZA9811687B (en) Chemical agent for stabilizing soil
AUPR152100A0 (en) Method for treating coral
AU2002211563A1 (en) Compounds useful for treating hypertriglyceridemia
AU2002225724A1 (en) Motilide compounds
HK1030610A1 (en) Improved process for antiparaistic agent.
AU2001239000A1 (en) Agent for treating hepatitis C containing Ukrain
AU1747501A (en) Novel ribose compounds
AU2001269496A1 (en) Surface treating agent for metal member
AU2002217285A1 (en) Compounds
AU2001262729A1 (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU2001243297A1 (en) Method for treating or preventing depression
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU138774S (en) Distiller